??? ??? ?? ???????. Pain, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Lidocaine nebulizer is administered at a dose of 10 mg / kg and is administered intravenously to placebo (distilled water 0.1 cc / kg) for patients. Intervention 2:
Sponsors
Deputy of Research of Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with limb trauma require pain relief with NRS upper 5/10 age between16-65 years
Exclusion criteria
Exclusion criteria: dissatisfaction of patient from this study Patient's allergy to lidocaine or morphine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of pain. Timepoint: 0,10,20,30,60 minutes. Method of measurement: Numeric Pain Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: 0,10,20,30,60minutes. Method of measurement: MmHg.;Diastolic blood pressure. Timepoint: 0,10,20,30,60minutes. Method of measurement: MmHg.;Heart rate. Timepoint: 0,10,20,30,60minutes. Method of measurement: In a minute.;Respiratory rate. Timepoint: 0,10,20,30,60minutes. Method of measurement: In a minute.;O2 saturation. Timepoint: 0,10,20,30,60minutes. Method of measurement: percent. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehzad Sadeghi ?Amroabadi
Deputy of Research of Tehran University of Medical Sciences
Outcome results
None listed